Full Thickness Resection or Endoscopic Submucosal Dissection for Difficult Colorectal Lesions.
Colorectal Neoplasms
About this trial
This is an interventional treatment trial for Colorectal Neoplasms
Eligibility Criteria
Inclusion criteria:
- patients of age >18 years
- Laterally Spreading Tumor Non Granular Type (LST-NG) ≤ 3cm in diameter
- "no-lift" colic injuries ≤ 3cm in diameter
- residual / recurrence on the scar of previous endoscopic resections of the colon ≤ 3cm in diameter
Exclusion criteria:
- pregnant women
- failure to accept or understand the consent to participate in the study
- patients with severe coagulopathies
- patients with short life expectancy (Charlson comorbidity index ≥8)
- patients with expired general clinical conditions (American Society of Anesthesiologists score ≥3)
Sites / Locations
- Ospedale Dei Castelli
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Endoscopic Submucosal Dissection (ESD)
Endoscopic Full-Thickness Resection (EFTR)
The Endoscopic Submucosal Dissection (ESD) procedures will be performed with the devices commonly used at the Services of Endoscopy of the Centers participating in the study. There are several models of knives on the market, produced by different companies, all considered equally effective by international guidelines.
The FTRD® (Full Thickness Resection Device; Ovesco Endoscopy, Tübingen, Germany) is the only over-the-scope device designed to undergo Endoscopic Full-Thickness Resection (EFTR) using a "clip-and-cut" technique. It consists of a 14 mm modified over-the-scope-clip (OTSC) mounted on the outside of a 23 mm cap, which has a preloaded 13 mm monofilament loop at the end. This device received the CE mark for the lower digestive tract in September 2014 and its efficacy and safety have been evaluated in preclinical studies and clinical trials.